MITRE and Brigham and Women’s Hospital Planning for Compass launch
ORLANDO, Fla.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/HIMSS19?src=hash” target=”_blank”gt;#HIMSS19lt;/agt;–MITRE announced Compass™, a first-in-class, open-source application to
collect minimal common oncology data elements, or mCODE™,
from electronic health records (EHR), today at the HIMSS19
Global Conference & Exhibition. Only three percent of adult
cancer patients participate in clinical trials, limiting access to high
quality data across multiple types of cancers. mCODE is a new data
standard under development that will facilitate breakthrough insights
into high-quality data for multiple cancer use cases.
“Advancements in cancer care and research are being driven by
high-quality, sharable data,” commented Dr.
Brian Anderson, chief clinical lead at MITRE. “Whereas mCODE is a
standardized set of cancer data points within health records, Compass is
a tool that extracts that data, organizes, and informs doctors,
patients, and researchers.”
Compass is a SMART (substitutable medical applications and reusable
technologies) on FHIR (fast healthcare interoperability resources)
application that extracts mCODE data elements from electronic health
records to deliver reports to providers and patients – empowering better
diagnosis, improved care planning, and shared decision making at the
point of care.
Most of the nearly 15
million individuals living with cancer in the U.S. have EHRs of some
sort. However, many of the 1,500 EHR systems in use are incompatible,
limiting the valuable information cancer researchers could pull from
Development of the mCODE data standard is led by the American
Society of Clinical Oncology (ASCO), working with MITRE and other
stakeholders, to improve data and records interoperability in oncology
care and research. An early version of mCODE core elements, reflecting
initial use cases, is open for comment and near ready for publication.
MITRE to collaborate with Brigham and Women’s Hospital on mCODE
MITRE and Brigham
and Women’s Hospital also announced their intentions to
strategically plan for an mCODE implementation pilot at the Boston
hospital. Teams are exploring the potential for a research study to
demonstrate the benefit of structured data entry, capture, display for
front line clinicians.
“We’re proud to collaborate with Brigham and Women’s to seek potential
opportunities to pilot the use of mCODE in a clinical research setting,”
Quina, principal investigator at MITRE. “Providers and patients are
already discussing the most important information related to care and we
want to ensure, through trial, that we are capturing the right data, at
the right times, to drive the best possible cancer research and
Compass preview and demonstrations during HIMSS19
On Tuesday, February 12, Dr. Brian Anderson, and Andre Quina will
preview Compass when they co-present mCODE:
A Cancer Model for a Learning Health System at HIMSS19.
Demonstrations of Compass will continue through Thursday, February 14th
at the MITRE kiosk, within the Federal Health IT Solutions Pavilion,
Explore mCODE and Compass:
mCODE and Compass with ASCO President Monica M. Bertagnolli, MD
What is mCODE? with Andre Quina
About The MITRE Corporation
MITRE’s mission-driven teams are dedicated to solving problems for a
safer world. Through our federally funded R&D centers and public-private
partnerships, we work across government to tackle challenges to the
safety, stability, and well-being of our nation.
mCODE is a trademark of the American Society of Clinical Oncology. Used